BrightGene Bio-Medical shareholder Advanced Manufacturing Fund reduces stake by 5.47 million shares, cashing out 217 million yuan

财中社··CN·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

BrightGene Bio-Medical announced on September 17 that shareholder Advanced Manufacturing Industry Investment Fund reduced its stake by a cumulative 5.47 million shares through centralized bidding and block trading, accounting for 1.26% of the company's total share capital, with total reduction proceeds of 217 million yuan. In the first half of 2026, BrightGene Bio-Medical achieved revenue of 678 million yuan and net profit attributable to the parent company of 58.93 million yuan.

Impact on assets 1

Others▼ · 1 stocks

Off-coverage companies 1

先进制造产业投资基金Private± Mixed
Capitalrelevance

The fund itself is the seller reducing its BrightGene stake; the article gives no driver for the fund's own outlook.

© 2026 MarketIVNews